Navigation Links
Avelas Biosciences to Present at 28th Annual Roth Conference
Date:3/8/2016

SAN DIEGO, March 8, 2016 /PRNewswire/ -- Avelas Bioscienes, Inc., a clinical stage oncology-focused company dedicated to improving cancer patient care from diagnosis through treatment, today announced that Carmine N. Stengone, president and chief executive officer, will present an overview of the company at the 28th Annual Roth Conference on Tuesday, March 15, 2016, at 12:20 p.m. PT at The Ritz Carlton, Laguna Nigel, California.

About Avelas Biosciences

Avelas Biosciences is a San Diego-based biotechnology company focused on developing technologies that advance a new standard-of-care for cancer surgery and therapeutic intervention. The company's lead candidate, AVB-620, is in a Phase 1b trial planned for enrollment of up to 39 breast cancer patients, assessing safety, pharmacokinetics and fluorescence properties using tissue image analysis. Avelas was founded by Avalon Ventures on technology from Nobel laureate Roger Y. Tsien, Ph.D. For additional information, please visit www.avelasbio.com.

 


'/>"/>
SOURCE Avelas Bioscienes, Inc.
Copyright©2016 PR Newswire.
All rights reserved


Related biology technology :

1. Avelas Biosciences Closes $6.85 Million in Series B Financing to Advance Real-Time Cancer Visualization Technology to Clinical Proof-of-Concept
2. Avelas Biosciences Initiates Phase 1b Trial of AVB-620 in Breast Cancer Patients
3. Representative Scott Peters Visits Avelas Biosciences
4. New Applications of Pressure BioSciences PCT Platform Prominently Featured at Scientific Conference on Technologies for Protein Research
5. Northstar Biosciences Launches All Natural Skincare Solutions
6. Further Advancements Made in the Development of an Improved Method For Rape Kit Testing Using Pressure BioSciences Patented Pressure Cycling Technology (PCT)
7. Sangamo BioSciences Announces Presentation At Regen Med Investor Day
8. Sangamo BioSciences Announces Presentation At The Needham Healthcare Conference
9. Centrillion Biosciences Announces Next-Gen Sequencing Innovation Grant Program
10. Quanta BioSciences qRT-PCR technology recommended in newly published CDC protocol for detection of H7N9 Avian Influenza
11. Regado Biosciences, Inc. Files Registration Statement for Proposed Initial Public Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/12/2019)... (PRWEB) , ... November 12, 2019 , ... ... DNA services, welcomed their new Director of Forensic Genealogy, Melinde Lutz Byrne, to ... Service (FGS) to ultimately provide investigative leads to law enforcement through proven ...
(Date:11/9/2019)... , ... November 08, 2019 ... ... artificial intelligence (AI)-powered technology for use in pathology research, today announced the ... biopsy samples from patients enrolled in the phase 3 selonsertib studies (STELLAR). ...
(Date:11/6/2019)... ... November 06, 2019 , ... LeadingBiotech ,?an ... today announces its East/West CEO conference to be held January 11-12, ... , Kicking off the week of the J.P. Morgan Healthcare Conference and other ...
(Date:11/5/2019)... ... November 05, 2019 , ... Focal Healthcare , ... for its Fusion Bx 2.0 prostate fusion biopsy solution. By combining information from ... 2.0 will give urologists across Europe the ability to perform targeted transrectal and ...
Breaking Biology Technology:
(Date:12/2/2019)... , ... December 01, 2019 , ... ... and greatest tools, technologies, and techniques to hit the life-science landscape. For more ... innovative products speeding work in laboratories and facilitating biological discovery. This year’s crop ...
(Date:11/27/2019)... ... November 26, 2019 , ... Smile ... Ellyn, IL practice for Invisalign® treatment. Invisalign orthodontics uses a series ... a misaligned bite, also known as malocclusion, present both functional and cosmetic concerns. ...
(Date:11/27/2019)... ... November 27, 2019 , ... ... device, equipped with surface electromyography (sEMG) sensors that measure and display muscle activity ... the specific muscles being targeted for treatment. Both patient and therapist can see ...
Breaking Biology News(10 mins):